Opinion|Videos|January 18, 2024

Rectal Spacers: Placement, Complications, and Management

Author(s)Brian Mazzarella, MD, Jeffrey T. Schiff, MD, MPH, Rizwan Nurani, MD

The panel provides clinical insights on the placement of rectal spacers, the management of toxicities, and the counseling of patients with prostate cancer following rectal spacer placement.

Episodes in this series

A panel of 5 experts on prostate cancer

EP. 1 Radiation Safety Considerations for Patients With Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 2 Urology Perspective on Radiation Toxicity in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 3 SBRT and Hypofractionation in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 4 Prostate Cancer: Best Candidates for Rectal Spacing

A panel of 5 experts on prostate cancer

EP. 5 Rectal Spacing With Proton Therapy and Brachytherapy in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 6 Patient-Centric Approach in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 7 Challenges and Complications With Rectal Spacing in Prostate Cancer

Varun Sundaram, MD, an expert on prostate cancer

EP. 8 Prostate Cancer: Hyaluronic Acid Spacers

Rizwan Nurani, MD, an expert on prostate cancer

EP. 9 Balloon Spacers in Prostate Cancer

Jeffrey T. Schiff, MD, MPH, an expert on prostate cancer

EP. 10 The Role of PEG Hydrogel Spacers in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 11 Prostate Cancer Treatment: Visibility Considerations With Radiation

A panel of 5 experts on prostate cancer

EP. 12 Pros and Cons of Rectal Spacer Types in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 13 Clinical Trials Investigating Rectal Spacers in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 14 Multidisciplinary Care in Prostate Cancer Treatment

A panel of 5 experts on prostate cancer

EP. 15 Rectal Spacers: Placement, Complications, and Management

A panel of 5 experts on prostate cancer

EP. 16 Academic Training and Advice for Clinicians Utilizing Rectal Spacers

A panel of 5 experts on prostate cancer

EP. 17 Future Landscape of Prostate Cancer and Rectal Spacers

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Doublet or triplet? Urologists weighs in on mCSPC options

ByUrology Times staff

September 10th 2026

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

ByMartin Schoen, MD, PhD,Hannah Clarke

September 10th 2026

App-based intervention aims to increase PSA screening among Black men

ByHannah Clarke

September 9th 2026

The critical role of advocacy in urologic oncology

ByRuchika Talwar, MD,Lan Anh Galloway, MD

September 9th 2026

Higher saturated fat intake associated with increased mortality in nonmetastatic prostate cancer

ByHannah Clarke

September 7th 2026

Latest CME

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC